MedTrace Logo

Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in Children

NCT01547910 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2014-08-21

No results posted yet for this study

Summary

The aim of this study is to evaluate efficacy of fish oil (EPA/DHA) in children with non-alcoholic fatty liver disease.

Conditions

  • Non-alcoholic Fatty Liver Disease

Interventions

DIETARY_SUPPLEMENT

Fish Oil

Fish oil given in supplementary dose

Sponsors & Collaborators

  • Medical University of Bialystok

    collaborator OTHER

  • Medical University of Silesia

    collaborator OTHER

  • Pediatric Municipal Hospital of Rzeszow, Poland

    collaborator UNKNOWN

  • Piotr Socha

    lead OTHER

Principal Investigators

  • Piotr Socha · Children's Memorial Health Institute, Warsaw, Poland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2012-03-31
Completion
2012-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01547910 on ClinicalTrials.gov